Presentation – The Issue-based Coalition on Health and Well-being
12 May 2017, Geneva, Switzerland
By Dr Zsuzsanna Jakab, WHO Regional Director for Europe
Presentation - Advancing health literacy and social mobilization for the United Nations 2030 Sustainable Development Goals
18 May 2017, Geneva, Switzerland
By Dr Zsuzsanna Jakab, WHO Regional Director for Europe
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 21st Congress of the European Association of Dental Public Health (1 October 2016 Budapest)
Contemporary health policy context in Europe: some opportunities and challenges
Presentation by Dr Zsuzsanna Jakab, WHO Regional Director for Europe. 8 March 2017, Israel
Presentation - Advancing health literacy and social mobilization for the United Nations 2030 Sustainable Development Goals
18 May 2017, Geneva, Switzerland
By Dr Zsuzsanna Jakab, WHO Regional Director for Europe
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 21st Congress of the European Association of Dental Public Health (1 October 2016 Budapest)
Contemporary health policy context in Europe: some opportunities and challenges
Presentation by Dr Zsuzsanna Jakab, WHO Regional Director for Europe. 8 March 2017, Israel
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 67th session of the WHO Regional Committee for Europe (Budapest, Hungary, 11–14 September 2017)
Dr Zsuzsanna Jakab, WHO Regional Director for Europe,Policy Dialogue on Health System and Public Health Reform in Cyprus: Health in the 21st Century, 26–27 September 2017, Nicosia, Cyprus
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the School of Public Health Management (Chisinau, Republic of Moldova, 24 November 2016)
Presentation by Dr Zsuzsanna Jakab,WHO Regional Director for Europe, at the Third High-level Meeting of the Small Countries Initiative, in Monaco, on 11–12 October 2016
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 7th Meeting of the European Advisory Committee on Health Research (Copenhagen, Denmark, 6 April 2016)
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe (Positioning the Veneto Region at the core of global and European health policies, 3-4 December 2015, Scuola San Giovanni Evangelista, Venice, Italy)
Resolutions and decisions of regional interest adopted by the Seventy-second World Health Assembly and the Executive Board at its 144th and 145th sessions
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 67th session of the WHO Regional Committee for Europe (Budapest, Hungary, 11–14 September 2017)
Dr Zsuzsanna Jakab, WHO Regional Director for Europe,Policy Dialogue on Health System and Public Health Reform in Cyprus: Health in the 21st Century, 26–27 September 2017, Nicosia, Cyprus
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the School of Public Health Management (Chisinau, Republic of Moldova, 24 November 2016)
Presentation by Dr Zsuzsanna Jakab,WHO Regional Director for Europe, at the Third High-level Meeting of the Small Countries Initiative, in Monaco, on 11–12 October 2016
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 7th Meeting of the European Advisory Committee on Health Research (Copenhagen, Denmark, 6 April 2016)
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe (Positioning the Veneto Region at the core of global and European health policies, 3-4 December 2015, Scuola San Giovanni Evangelista, Venice, Italy)
Resolutions and decisions of regional interest adopted by the Seventy-second World Health Assembly and the Executive Board at its 144th and 145th sessions
Workshop 5 - Brainstorming & Policy Development session: Social Aspects
"Feedback from the 15 National Conferences on social aspects"
Britta Berglund, Ehlers Danlos, Sweden
Presentation by Dr Angel Kunchev, Bulgarian Ministry of Health, on implementation in Bulgaria of the WHO Guide to Tailoring Immunization Programmes (TIP), at WHO/Europe Immunization Programme Managers Meeting, Antalya, Turkey, March 2014
UNDP Key Achievements in introducing Sustainable Procurement in the Health Se...UN SPHS
On 22nd Septemeber 2016, SPHS Coordinator Rosemary Kumwenda and UNDP Greening Health Systems Specialist Ignacio Sanchez Diaz deliver a presentation on UNDP's key achievements in introducing sustainable procurement in the health sector at the GEF Project Inception Workshop in South Africa.
Health literacy in the WHO European Region, Dr Bente Mikkelsen, Director, Noncommunicable Diseases and Promoting Health through the Life-course / Kristina Mauer-Stender, Acting Director, Information, Evidence, Research and innovation (WHO Regional Office for Europe)
Reported measles cases for the period November 2020—October 2021 (data as of 02 December 2021).A monthly summary of the epidemiological data on selected vaccine-preventable diseases in the WHO European Region
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
2. What is the Issue-based Coalition (IBC)?
• A pan-European enabling mechanism to facilitate and promote the
improvement of health and well-being for all at all ages in the Region,
with a special focus on leaving no one behind
• A coalition of partners: United Nations agencies (the Food and
Agriculture Organization of the United Nations, the Joint United Nations
Programme on HIV/AIDS, the United Nations Children’s Fund, the
United Nations Development Programme, the United Nations Office for
Project Services, the United Nations Population Fund (UNFPA), the
United Nations Refugee Agency (UNHCR) and UN Women) and other
intergovernmental organizations and stakeholders, which will
coordinate their activities
3. Specific objectives for 2017–2019
• Strengthen the regional partnership and involvement of stakeholders at all levels of
governance support Member States in the implementation of the health and related
targets of the Sustainable Development Goals (SDGs).
• Map existing norms, policies and standards and identify priorities, opportunities and gaps
in programming and in developing mechanisms in order to address them.
• Provide coherent and timely programming as well as policy and/or normative guidance
and technical support on health-related issues at the regional and country levels.
• Increase the effective and efficient use of human and financial resources within and
among United Nations agencies and partners on health-related initiatives and
interventions, including regional joint resource mobilization efforts.
• Improve coordination, communication and information-sharing on key lessons and good
practices on the basis of the focus to leave no one behind due to poor health.
7. Main types of joint activities
• Joint advocacy initiatives
• Expertise and thematic rosters
• Policy alignment
• Sharing of knowledge and position papers
• Specific country implementation
8. Workstream I
Health
throughout the
life-course
Communicable
Diseases
Universal
Health
Coverage
Migration
Coordination
Focus: health throughout the life-course
SDG targets: 3.1, 3.2, 3.7 and Goal 5
Focus areas for 2017–2019:
• Neonatal survival in the high-burden countries of central Asia and
the Caucasus
• Quality of care for mothers and children in primary care facilities
and hospitals
• Health promotion at schools and development of responsive school
health services
• Implementation of the European Strategy on women’s health and
well-being
9. Workstream I
Health
throughout the
life-course
Communicable
Diseases
Universal
Health
Coverage
Migration
Coordination
Focus - Child and maternal health
SDG Target: 3.1, 3.2, 3.7 and goal 5
Focus areas 2017-2019:
• neonatal survival in the high burden countries of Central Asia and the
Caucasus
• quality of care for mothers and children in primary care facilities and
hospitals
• health promotion at schools and development of responsive school
health services
• Implementation of the European women’s health and well-being
strategy
Planned products:
- Neonatal survival
- Workshops in 6 countries of central Asia and the Caucasus
- A report on the use of the Integrated Management of Childhood Illness
strategy in Europe
- A quality-improvement approach to hospital care for mothers and
children in 3 countries
- Schools
- Curricula for school-based health education for 10 countries
- Women
- A monitoring framework for the European women’s health strategy
- A tool for the subnational assessments of women’s health and well-being
- Strategic areas for an IBC on gender
10. Workstream II
Health
throughout the
life course
Communicable
diseases
Universal
Health
Coverage
Migration
Focus: communicable diseases
SDG targets: 3.3, 3.B
Focus area for 2017–2019:
• Reducing the burden of tuberculosis, HIV
and viral hepatitis in European Member
States
Planned products:
• United Nations joint paper
• Global Ministerial Conference
11. Workstream III
Health
throughout the
life course
Communicable
Diseases
Universal
health
coverage
Migration
Focus: universal health
coverage
SDG targets: 3.8, 3.B
Focus areas for 2017–2019:
• Improving access to safe, effective, quality
and affordable medicines
• Building capacity for the provision of medical
products by:
sharing experiences, training and
supporting systems for the provision of
medical products in the Region
sharing experiences, training and
supporting systems for regulation of and
access to medical products in the Region
12. Workstream III
Health
throughout the
life course
Communicable
Diseases
Universal
health
coverage
Migration
Focus: universal
health coverage
SDG targets: 3.8, 3.B
Focus area 2017-2019: Medical Products
• Building capacity through
• sharing experiences, training and
supporting systems for provision of
medical products in the Region
• sharing experiences, training and
supporting systems for the regulation
and access to medical products in the
Region
Planned products:
• Regional Procurement and Supply Management
Practitioners’ Forum developed by end of 2017
• Training workshops in 4 countries targeting national
staff and counterparts
• Joint consultation with medical product industry on
demand for and quality of products, and reliable
product forecasts shared with the industry for a
number of essential health products
• Training and capacity-building related to WHO
guidance, norms and standards for health product
regulation
13. Workstream IV
Health
throughout the
life course
Communicable
Diseases
Universal
Health
Coverage
Migration
Focus: migration
SDG targets: 10.7, Goal 3 and others
Focus areas for 2017–2019:
• Supporting Member States to strengthen preparedness and
capacity for adequately managing the public health challenges
related to large-scale migration through an interagency
collaboration and delivery of country support
• Supporting Member States through the development of technical
guidance materials, and through the provision of distance-learning
opportunities in the field of migration and health
14. Workstream IV
Health
throughout the
life course
Communicable
Diseases
Universal
Health
Coverage
Migration
Focus – Migration
SDG Target: 10.7, goal 3 and others
Focus area 2017-2019: Supporting Member States
• to strengthen preparedness and capacity for adequately managing
the public health challenges related to large-scale migration
through an inter-agency collaboration and delivery of country
support
• through development of technical guidance materials, and through
the provision of distance-learning opportunities in the field of
migration and health
Planned products:
- A regional interagency contingency plan
- Assessment of 3 countries using the Toolkit for assessing health
system capacity to manage large influxes of refugees, asylum-seekers
and migrants (developed by WHO in collaboration with the UNHCR,
the UNFPA and the International Organization for Migration)
- New technical guidance materials and distance-learning opportunities
- Convening of an annual meeting of the Knowledge Management
Committee
15. Coordination
Coordination
One IBC meeting per year
Implementation plan
Compendium on existing capacities
Advocacy
Communication plan
Joint guidance on leaving no one behind
Identification of gaps and emerging needs
Monitoring and evaluation
Multi- and intersectoral
streamlining
Joint advocacy paper on implementing the
recommendations of the 5th Ministerial
Conference on Environment and Health
Organization of an IBC meeting to follow
up on the 2016 Paris high-level conference
Second conference on the theme
“Working together for better health and
well-being”
16. Next steps
• Set second IBC meeting dates (2 days)
– Streamline vertical and horizontal coordination
– Agree on a detailed implementation plan for 2017–2018
– Agree on joint communication activities
• Regular progress reports
• Regular communication within and across organizations
• Creation of an inter- and multisectoral platform
• Integration into a United Nations Development Assistance
Framework
Editor's Notes
Dear Colleagues and friends,
It is a big pleasure to briefly present where we are with the issue based coalition on health and well’being. In November we came together as agencies to discuss the content of the IBC. After this we developed a joint workplan. I will present here briefly the content of this workplan and next steps.
Read slide
read
For workstreams were identified, which reflect:
areas of joint cooperation;
high urgency and high political importance,
common high burden of diseases or priorities across all countries (addressing the unmet),
populations in particularly vulnerable conditions (addressing those most at need),
existing commitments that ultimately will help to implement the SDGs goals and targets and building on areas with existing cooperation.
Advancing health and well-being for all at all ages, means also improving the social, economic, environmental, commercial, and cultural determinants of health, such as
promoting good quality early childhood development, education, employment and living conditions;
Promoting active labour market policies for a healthy workforce;
coordinating social protection ‘
ending gender inequalities, violence and exclusion and strengthening women’s safety, building women’s human capital and capabilities
Environmental protection
etc
Therefore, in addition, a workstream an overall coordination, co-production, and communication was identified, which includes cross-cutting aspects, such as:
Health equity, gender and human rights;
Multisectoral action for health and well-being, through the Regional Platform for Working Together for Better Health and Well-being and the Environment and Health process;
Monitoring of SDG implementation and disaggregated coherent data.
One existing area, where mechanisms are already established, namely non-communicable diseases, will be further considered and cooperation further enhanced.
read
Workstream 1 on health throughout the lifecourse will first focus on child and maternal health. In particular to eliminate preventable neonatal and childhood deaths and enable children in the Region to realize their full potential for health and development. Newborn mortality is now the highest burden in most countries and poor quality of health care is one of the main barriers to its reduction. Childhood development, health behaviors at school and adolescent health has been insufficiently addressed. Every year, 1 million children still do not receive all scheduled vaccinations. Child maltreatment, adolescent tobacco use, mental health and physical inactivity are significant concerns for children and adolescents across the Region
(rest to read out)
Workstream 2 was identified as the European Region is the only region in the world where HIV incidence (number of newly diagnosed cases reported) (target 3.3) continues to rise rapidly and the region with highest multidrug resistant TB.
Read slide
Achieving Universal health coverage is one of the targets under the health goal. Within UHC, at the meeting of our agencies we identified “access to safe, effective, quality, and affordable medicines”, a key issue to further work on. Latest available data for the European Region shows large variation between countries in public expenditure on pharmaceuticals ranging from less than 10% in countries like The Netherlands, Norway and Denmark, to more than 30% of total health care expenditure in Serbia, Hungary, Tajikistan and Georgia. Medicines, vaccines and health products often make up the largest portion of countries’ (and households’) health spending – their impact on health financing places them in a central position in all discussions.
Read rest of slide
Following the recent increase in arrivals of refugees and migrants to the European Region, countries have called for enhanced public health action to protect and promote the health of mobile populations, thus facilitating their integration into national health systems and host societies. Responding to this emerging need, the WHO Regional Committee for Europe approved in September 2016 the first Strategy and Action Plan on Refugee and Migrant Health in the WHO European Region. This workstream therefor focuses on working together around the nine areas of joint cooperation.
Read the rest
Within the overall workstream on coordination, advocacy and multi and intersectoral action, we plan to hold
Face to face IBC meeting per year, and need to identify the date for the next meeting
A compendium on existing tools and capacities, is already under production by many agencies, we need to see now how to best with least resources we can do this
There is a big need for communication between us but also to the oputside world. We need to discuss on how to make these IBCs most visible
We also propose as a follow up to the Paris and the Ministerial Conference on Environment and Health to develop joint papers on implementation, as well as to discuss the next multisectoral meeting.